Detalhe da pesquisa
1.
Neurological symptoms in essential thrombocythemia: impact of JAK2V617F mutation and response to therapy.
Eur J Haematol
; 96(6): 593-601, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26205460
2.
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC).
Clin Rheumatol
; 42(2): 359-370, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36169798
3.
Asymptomatic central pontine myelinolysis without hyponatriemia in diffuse large B cell lymphoma.
Neurol Sci
; 37(12): 2035-2037, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27488303
4.
Correction to: Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC).
Clin Rheumatol
; 42(2): 641-642, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36264401
5.
Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score.
Bone Marrow Transplant
; 53(4): 461-473, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29330395
6.
Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
Clin Lymphoma Myeloma Leuk
; 15(4): 208-13, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25468321